Marketing and Communications Intern (Summer 2025)
Department: Marketing and Communications
Paige Butler
Marketing and Communications Intern (Fall 2025)
Department: Marketing and Communications
Fundraising Intern (Fall 2025)
Department: Development
Fundraising Intern (Summer 2025)
Department: Development
Director of Development, Major and Planned Gifts
Department: Development
Senior Manager of Corporate Partnerships and Community Engagement
Department: Development
Robert Albero Gallego, PhD
Researcher Spotlight: Robert Albero Gallego, PhD COLUMBIA UNIVERSITY Angioimmunoblastic T-cell lymphomas (AITLs) are aggressive forms of blood cancer and are often resistant to conventional chemotherapy. Certain mutations have been to be very common in AITLs, including mutations in the TET2…
Preteesh Jain, MD, PhD
Researcher Spotlight: Preteesh Jain, MD, PhD UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER Chemotherapy-sparing treatment regimens are of great interest for many patients with lymphoma due to the variety of short- and long-term toxicities associated with These therapies. To this…
Haopeng Yang, PhD
Researcher Spotlight: Haopeng Yang, PhD UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER Super-enhancers are regions of the genome responsible for regulating expression of an unusually high number of genes. For his Lymphoma Research Foundation-funded project, Dr. Yang is characterizing the…
Min Xia, PhD
Researcher Spotlight: Min Xia, PhD WEILL CORNELL MEDICINE Among the different subtypes of diffuse large B-cell lymphoma (DLBCL), ABC-DLBCL represents one of the most aggressive forms with low response rates to standard chemotherapeutic approaches. Improved treatment approaches in this space…